Vimarsana.com

Latest Breaking News On - Analyst recommendations for eyepoint pharmaceuticals - Page 1 : vimarsana.com

Analysts Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Target Price at $34.00

Analysts Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Target Price at $34.00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Securities-exchange-commission
Hermes-inc
Insider-activity-at-eyepoint-pharmaceuticals
Eyepoint-pharmaceuticals-inc
Franklin-resources-inc
Analyst-recommendations-for-eyepoint-pharmaceuticals
Nasdaq
Eyepoint-pharmaceuticals-price-performance
News-ratings-for-eyepoint-pharmaceuticals-daily
Jennison-associates
Jpmorgan-chase-co

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Given Consensus Recommendation of "Buy" by Analysts

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Given Consensus Recommendation of "Buy" by Analysts
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

China
Robertw-baird
China-universal-asset-management-co
Eyepoint-pharmaceuticals
News-ratings-for-eyepoint-pharmaceuticals-daily
Jpmorgan-chase-co
Eyepoint-pharmaceuticals-inc
Tower-research-capital
Analyst-recommendations-for-eyepoint-pharmaceuticals
Sherbrooke-park-advisers
Investment-advisers

StockNews.com Downgrades EyePoint Pharmaceuticals (NASDAQ:EYPT) to Sell

StockNews.com Downgrades EyePoint Pharmaceuticals (NASDAQ:EYPT) to Sell
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Vanguard-group-inc
Hermes-inc
Eyepoint-pharmaceuticals
Eyepoint-pharmaceuticals-inc
Jennison-associates
Institutional-investors-weigh-in-on-eyepoint-pharmaceuticals
Securities-exchange-commission
Jpmorgan-chase-co
Eyepoint-pharmaceuticals-company-profile
Eyepoint-pharmaceuticals-stock-down
News-ratings-for-eyepoint-pharmaceuticals-daily

EyePoint Pharmaceuticals (NASDAQ:EYPT) Downgraded by StockNews.com

EyePoint Pharmaceuticals (NASDAQ:EYPT) Downgraded by StockNews.com
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Robertw-baird
Jennison-associates
Institutional-trading-of-eyepoint-pharmaceuticals
Franklin-resources-inc
First-turn-management
Eyepoint-pharmaceuticals-company-profile
Eyepoint-pharmaceuticals-inc
Securities-exchange-commission
Hermes-inc
Eyepoint-pharmaceuticals
Analyst-recommendations-for-eyepoint-pharmaceuticals

EyePoint Pharmaceuticals (NASDAQ:EYPT) Price Target Cut to $38.00 by Analysts at Robert W. Baird

EyePoint Pharmaceuticals (NASDAQ:EYPT) Price Target Cut to $38.00 by Analysts at Robert W. Baird
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China
Robertw-baird
China-universal-asset-management-co
Investment-advisers
Nasdaq
Jpmorgan-chase-co
Analyst-recommendations-for-eyepoint-pharmaceuticals
Eyepoint-pharmaceuticals-inc
Eyepoint-pharmaceuticals-trading
Tower-research-capital
Eyepoint-pharmaceuticals-company-profile

EyePoint Pharmaceuticals (NASDAQ:EYPT) PT Lowered to $38.00

EyePoint Pharmaceuticals (NASDAQ:EYPT) PT Lowered to $38.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China
Robertw-baird
Tower-research-capital
Eyepoint-pharmaceuticals-trading
Eyepoint-pharmaceuticals-inc
Analyst-recommendations-for-eyepoint-pharmaceuticals
Jpmorgan-chase-co
Institutional-trading-of-eyepoint-pharmaceuticals
Eyepoint-pharmaceuticals
Toth-financial-advisory-corp
News-ratings-for-eyepoint-pharmaceuticals-daily

Brokerages Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Price Target at $33.86

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has received an average recommendation of “Buy” from the seven brokerages that are presently covering the stock, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year […]

United-states
American
Darioa-paggiarino
Tower-research-capital
Securities-exchange-commission
Analyst-recommendations-for-eyepoint-pharmaceuticals
Institutional-investors-weigh-in-on-eyepoint-pharmaceuticals
American-international-group-inc
Nasdaq
News-ratings-for-eyepoint-pharmaceuticals-daily
Investment-advisers

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives $33.86 Consensus Price Target from Brokerages

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been assigned a consensus rating of “Buy” from the seven ratings firms that are presently covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokers that have issued ratings on the stock […]

Darioa-paggiarino
Analyst-recommendations-for-eyepoint-pharmaceuticals
News-ratings-for-eyepoint-pharmaceuticals-daily
Franklin-resources-inc
Securities-exchange-commission
Vanguard-group-inc
Jpmorgan-chase-co
Eyepoint-pharmaceuticals
Eyepoint-pharmaceuticals-inc
Pricet-rowe-associates-inc
Eyepoint-pharmaceuticals-price-performance

vimarsana © 2020. All Rights Reserved.